Table 2.
Cardiac CT, carotis Doppler ultrasound, and retinal angiography findings and biomarkers in patients with NAFLD and controls.
| with NAFLD N = 29 |
Controls N = 22 |
p value NAFLD vs. Controls |
|
|---|---|---|---|
| Coronary artery disease (stenosis > 50%) | 30% | 15% | 0.001 |
| Coronary Plaques%Soft Plaques | 70%50% | 30%30% | 0.010.01 |
| IMT, mean Right Carotis (mm) | 0.90 ± 0.19 | 0.8 ± 0.10 | 0.03 |
| Left Carotis (mm) | 0.98 ± 0.30 | 0.8 ± 0.10 | 0.27 |
| Mean Carotis Plaques% | 60% | 40% | 0.01 |
| Retinal artery diameter | 92.4 ± 13.08 | 100.56 ± 7.1 | 0.04 |
| Retinal vein diameter | 136.37 ± 14.42 | 141.5 ± 7.05 | 0.2 |
| AVR | 0.66 ± 0.06 | 0.71 ± 0.02 | 0.01 |
| CRP | 0.41 ± 0.9 | 0.30 ± 0.3 | 0.02 |
| MDA(mM) | 0.09 ± 0.05 | 0.11 ± 0.05 | 0.09 |
| Paroxonase (mM/min) | 0.55 ± 0.1 | 0.57 ± 0.1 | 0.4 |
| HOMA | 4.0 ± 3.4 | 2.0 ± 1.0 | 0.001 |
Intima media thickness (IMT), arteriole-to-venule ratio (AVR); malondialdehyde (MDA), C-reactive protein (CRP), homeostasis model assessment of insulin resistance HOMA.